Consensus Guidelines on Improving the Management of HAE
William Lumry, MD
Participated as a faculty member in the 2013 Consensus Guidelines program
Dr. Lumry is a board certified Internist and Allergist. He is in private practice in Dallas, Texas treating adults and children with allergic diseases and asthma. He is a Clinical Professor of Internal Medicine at the University of Texas Southwestern Medical School in Dallas and teaches at Parkland Memorial and Presbyterian Hospitals in Dallas. He received his medical degree from the University of Texas Medical Branch at Galveston, completed his internal medicine training at Washington University in St. Louis and received his clinical and research fellowship in allergy and immunology from Scripps Clinic in La Jolla, California.
Marc A. Riedl, MD, MS
Professor of Medicine UCSD Allergy and Immunology,
Department of Medicine Clinical Director, US HAEA Angioedema Center at UCSD
Dr. Riedl has disclosed the following relevant financial interests:
Research Support: Dyax/Shire, CSL Behring, Ionis Pharming
Dr. Riedl participated as a faculty member in the 2013 Consensus Guidelines program, the Angioedema in the ED program and authored the Angioedema Chronic Care Patient Simulation
As a board-certified allergist/immunologist Dr. Riedl specializes in diagnosing and treating angioedema, immune deficiency diseases, asthma, anaphylaxis, food and medication sensitivity, and other related conditions. Dr. Riedl is the clinical director of UC San Diego Health’s U.S. HAEA Angioedema Center, which offers comprehensive evaluations and treatment options for people with all forms of angioedema.
An international thought leader on angioedema, Dr. Riedl is a member of the U.S. Hereditary Angioedema Association’s Medical Advisory Board and has been a driving force behind hereditary angioedema research. He is extensively published, and his work has appeared in The New England Journal of Medicine, JAMA, Allergy, and Asthma and Immunology, among others.
As a professor in the Department of Medicine at UC San Diego School of Medicine, Dr. Riedl mentors and instructs medical students, residents and fellows. He serves as the training program director for Allergy and Immunology Fellowship Program. Dr. Riedl is also involved in numerous clinical research trials that study novel therapeutics to prevent and treat hereditary angioedema attacks. He lectures frequently at both national and international medical conferences. He serves on the editorial board for Clinical Immunology and the Journal of Asthma, and is reviewer for many medical journals.
Dr. Riedl completed a fellowship in clinical immunology and allergy at UCLA School of Medicine and a residency in internal medicine at Barnes-Jewish Hospital of Washington University School of Medicine in St. Louis. He earned his medical degree from University of Chicago Pritzker School of Medicine. Dr. Riedl is board-certified in allergy and immunology and clinical pharmacology.
He is a member of numerous professional organizations, including the American Academy of Allergy, Asthma & Immunology, the American College of Allergy, Asthma & Immunology, and the Clinical Immunology Society. Dr. Riedl has also served on the Special Emphasis Grant Review Committee for National Institutes of Health (NIH)-National Institute of Environmental Health Sciences (NIEHS), and as an appointed consultant for the U.S. Food and Drug Administration’s Advisory Committee.